Tandem Diabetes Care Inc (NAS:TNDM)
$ 49.68 -1.71 (-3.33%) Market Cap: 3.21 Bil Enterprise Value: 3.33 Bil PE Ratio: 0 PB Ratio: 13.18 GF Score: 79/100

Tandem Diabetes Care Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 03:15PM GMT
Release Date Price: $42.53 (+6.54%)
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Well, it looks like Matt is not here yet. And so maybe what I can do is to start off by giving you kind of an update on how the business is doing. And if you guys have any questions, more than happy to field them right here. There he is.

I will start off by saying that last year was a challenging year for Tandem. We anticipated that we would see some challenges from COVID and from our competition but we didn't really anticipate that we would be -- the macroeconomic (inaudible) that was somewhat of a surprise to us. And if you go through the year, certainly in the back half of the year as the competition came to market, we did see our growth rate slow.

When you look at exactly how that happened, it was primarily from MDI conversions, people who are moving from pens and needles (inaudible). And I think that we finished the year, we actually grew 15%. And rather than try to just evaluate all of these factors and how they're going to affect us this coming year in 2023, we took a relatively conservative approach.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot